Get started

Stockstobuy

Will earnings Season push S&P to new lows? With the latest US earnings season underway, plenty of investors are still wary of making investment decisions. They hope that the earnings results will serve as guidance as to how the next few months will look like before factoring in fresh monetary policies and inflationary measures. Earnings and the S&P 500 In the lead up to the earnings season, A Bloomberg survey showed that more than 60% of its 724 respondents believed the third-quarter earnings season will push the S&P 500 index lower. But data from American financial data and software company FactSet is painting a different picture, revealing analysts' expectation of a roughly 7.5% growth in the earnings for S&P 500 companies for this year and the next, despite investors' fear of a worsening economic downturn. Federal Rate decision While investors are seeking clarity from the third-quarter earnings season, industry players and analysts are united in the belief that the Federal Reserve's rate decision will likely override any positive momentum and have major impact to stock performance moving forward. JPMorgan CEO Jamie Dimon said depending on whether the Federal Reserve engineers a soft or hard landing for the economy, the S&P 500 could fall another 20%. It came with a warning on Monday that the US would likely fall into a recession over the next six to nine months. In contrast, the International Monetary Fund, said Tuesday that it expects the US economy to grow 1%. The price of goods and services in the US continued to grow in September, with the consumer price index 8.2% higher than the prior-year period. The Federal Reserve and some economists maintain that demand generated by a hot labor market and higher wages fuel inflation and that higher unemployment and interest rates are the solution to bring it down. President of Yardeni Research Ed Yardeni expects the S&P 500 to wait until the end of 2023 to be back at its peak, while other analysts are betting on an improving outlook that will push stock prices higher, the New York Times reported.
SP:SPX
by BlackBull_Markets
Twitter ($TWTR) Can Rise Much Higher, Wait For A BreakoutTraders and Investors, Twitter currently is at an important structure zone. If that zone is broken and confirmed, it can rise much higher to the targets shown in the chart. Please support this analysis by liking and sharing. 👍🙂 Rules: 1. Never trade too much 2. Never trade without a confirmation 3. Never rely on signals, do your own analysis and research too ✅ If you found this idea useful, hit the like button, subscribe and share it in other trading forums. ✅ Follow me for future ideas, trade set ups and the updates of this analysis ✅ Don't hesitate to share your ideas, comments, opinions and questions. Take care and trade well -Vik ____________________________________________________ 📌 DISCLAIMER The content on this analysis is subject to change at any time without notice, and is provided for the sole purpose of education only. Not a financial advice or signal. Please make your own independent investment decisions. ____________________________________________________
NYSE:TWTRLong
by vikinsa
EVFM 53X Upside potential according to Morgan Stanley !EVFM Evofem Biosciences has a big upcoming catalyst: Its Phase 3 clinical trial evaluating Phexxi for the prevention of chlamydia and gonorrhea in women is on track to report top-line data from this landmark trial in mid-October, so we are one week away from results! Positive study outcomes would enable potential U.S. approval for prevention of these sexually transmitted infections in 2023. Evofem`s Phexxi whas already approved in Nigeria, the most populous country in Africa and the seventh largest country in the world, 3 days ago. On 4/12/2022 Jeffrey Hung from Morgan Stanley Boosted the Price Target for EVFM to Underweight, from $7.95 to $8.55. On 8/15/2022 HC Wainwright Boosted the Price Target to $4.00, giving a Buy Rating. Now the stock is trading at all time low, $0.16, while 4 months ago it was trading 10X higher. In my opinion this is a premium call and a great buy opportunity ahead of a Big upcoming catalyst for EVFM Evofem Biosciences. Looking forward to read your opinion about it.
OTC:EVFMLong
by TopgOptions
1
ADBE ADD TO WATCHLIST!🔸️Ticker Symbol: ADBE🔸️Timeframe: 4 Hour🔸️Investment Strategy: Long TECHNICAL ANALYSIS: ADBE on the 4H timeframe is setting up nice to see an increase in value if we can stay in this current trend. Our white line representing money momentum on the bottom dashboard indicator is shifting to the upside and we also have a green middle band illuminated meaning bull market momentum. The final confirmation that I want to be looking out for is a green dot meaning a key ema crossover to the upside which would just give me added confirmation that taking a long position on ADBE could result in some nice gains. Thanks for following! 🔔 Follow for daily stock, crypto and forex technical analysis. ⚠️ Trading is risky and I understand nothing is guaranteed. Proper risk management should be in place at all times to minimize losses. Please consult a financial advisor before trading. All Inclusive Trading LLC is not a financial advisor and may not be held liable for any losses which may occur.
NASDAQ:ADBELong
by TrendsiTrades
AAPL: Ready For BounceTicker Symbol: $AAPL ️Timeframe: 1D Investment Strategy: LONG (SHORT TERM) REJECTION OF 50SMA AND AT SUPPORT LEVEL STOCHASTIC SHIFTING UP AND RSI OVERSOLD. Follow for daily stock, crypto and forex technical analysis. Trading is risky, and I understand nothing is guaranteed. Proper risk management should be in place at all times to minimize losses. Please consult a financial advisor before trading. All Inclusive Trading LLC is not a financial advisor and may not be held liable for any losses which may occur.
NASDAQ:AAPLLong
by Red_Green-TA
FWBI 81X Upside Potential according to this Analyst!On 5/26/2022 Roth Capital brokerage Lowered the Price Target for First Wave BioPharma, Inc. (FWBI) from $600.00 to $270.00 giving a Buy Rating for the stock! The stock is now at a historic low: $3.31. In January 2021 it was $788. Just to reach the Analyst Price Target, it need to grow 81.5X from this level. The Market cap is extremely low: 4.58 Mil. 81X would be $371 Mil. And wouldn`t be too much, if we look at their pipeline: 2 candidates reaching Phase 3 clinical trials, 3 candidates in Phase 2 and one in Phase one, in the following fields: Digestive/Nutritional Diseases, Inflammatory Diseases and Oncology. It can explode anytime. Even though the institutional ownership it`s not high, some of the shareholders that recently reported increasing stakes in the company are: Goldman Sachs, Blackrock and Jane Street Group. This one is a premium call in my opinion. Looking forward to read your opinion about it.
FLong
by TopgOptions
9
XOM SELL SIGNAL ILLUMINATED🔸️Ticker Symbol: XOM 🔸️Timeframe: 4 Hour 🔸️Investment Strategy: Short TECHNICAL ANALYSIS: XOM is currently flashing a sell signal on our 4H timeframe and could see the price decreasing over the next week. Our money momentum indicator on the bottom dashboard is shifting lower indicating money is flowing out of the market. We also have a red dot representing a key ema crossover to the downside. With both of these in combination I do believe we have the potential to see XOM head lower to $96 and the first level of support followed by $94.60. Thanks for following! 🔔 Follow for daily stock, crypto and forex technical analysis. ⚠️ Trading is risky, and I understand nothing is guaranteed. Proper risk management should be in place at all times to minimize losses. Please consult a financial advisor before trading. All Inclusive Trading LLC is not a financial advisor and may not be held liable for any losses which may occur.
NYSE:XOMShort
by TrendsiTrades
SPY Technical Update 8/26/22🔸️Ticker Symbol: SPY 🔸️Timeframe: 4 Hour 🔸️Investment Strategy: Neutral TECHNICAL ANALYSIS: SPY did have a selloff this morning after Powell made his speech but not all is lost. If we take a look at the bigger picture and overall market trend, we are still heading in a bullish pattern. Our linear regression indicator is still heading in an upward direction, our white line on the dashboard representing money momentum is still heading higher and we have a green dot representing a key ema crossover to the upside. If we can hold this middle deviation level at approx. $410 the SPY could see a reversal and start to head higher. If for some reason we do see a gap down I would keep an eye on the $405 level which is the strongest level of support if we break for a bounce play. Thanks for following! 🔔 Follow for daily stock, crypto and forex technical analysis. ⚠️ Trading is risky, and I understand nothing is guaranteed. Proper risk management should be in place at all times to minimize losses. Please consult a financial advisor before trading. All Inclusive Trading LLC is not a financial advisor and may not be held liable for any losses which may occur.
AMEX:SPY
by TrendsiTrades
ADBE: TRENDSI ATS CONFIRMATION; ADBE IS TO REACH 415Ticker Symbol: $ADBE ️Timeframe: 4H ️REJECTION OF 200SMA ️Investment Strategy: LONG TECHNICAL ANALYSIS: TRENDSI ATS MONEY MOVEMENT SHIFTING UP : BULLISH LINEAR REGRESSION + TRENDSI: AT THE BOTTOM, WHICH IS AT THE SUPPORT REJECTION OF 200SMA ON 4HR AND REJECTION OF 50SMA ON DAILY TF RSI OVERSOLD AND STOCHASTIC SHOWING BULLISH MOVEMENT. CONFIRMATION I AM WAITING: TRENDSI ATS GREEN LINE WITH GREEN DOT Follow for daily stock, crypto and forex technical analysis. Trading is risky, and I understand nothing is guaranteed. Proper risk management should be in place at all times to minimize losses. Please consult a financial advisor before trading. All Inclusive Trading LLC is not a financial advisor and may not be held liable for any losses which may occur.
NASDAQ:ADBELong
by Red_Green-TA
MSFT Don't Miss This Move!🔸️Ticker Symbol: MSFT 🔸️Timeframe: 4 Hour 🔸️Investment Strategy: Long TECHNICAL ANALYSIS: MSFT is currently sitting on a strong level support at $276. We are in a bull regression trend which is why I want to be focusing on long position in the market at the moment. We do have our bottom dashboard indicator suggesting that we are in a buying or accumulating stage in the market since we are testing this bottom green section. Historically this area in a bull trend has acted as a good indication that MSTF could see a push higher in value. If we do continue in this trend, I do believe a retest of $290 is not out of the question come next week. Thanks for following. 🔔 Follow for daily stock, crypto and forex technical analysis. ⚠️ Trading is risky, and I understand nothing is guaranteed. Proper risk management should be in place at all times to minimize losses. Please consult a financial advisor before trading. All Inclusive Trading LLC is not a financial advisor and may not be held liable for any losses which may occur.
NASDAQ:MSFTLong
by TrendsiTrades
1
AAPL Signaling Bullish Continuation 🔸️Ticker Symbol: AAPL 🔸️Timeframe: 4 Hour 🔸️Investment Strategy: Long TECHNICAL ANALYSIS: AAPL is looking promising to end the week strong to the upside. I do think if we can stay in this bull trend, we could potentially see AAPL hit $175 either tomorrow August 26 or early next week. Our bottom dashboard indicator does suggest that money is still flowing into the market, along with a green dot illuminated representing a key ema crossover to the upside. With both of these indicators pointing to bullish signs I do think if we can hold support at $168 AAPL does have the ability to retest its previous resistance level around $175. Thank you for following! 🔔 Follow for daily stock, crypto and forex technical analysis. ⚠️ Trading is risky, and I understand nothing is guaranteed. Proper risk management should be in place at all times to minimize losses. Please consult a financial advisor before trading. All Inclusive Trading LLC is not a financial advisor and may not be held liable for any losses which may occur.
NASDAQ:AAPLLong
by TrendsiTrades